Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
暂无分享,去创建一个
K. Khunti | M. Jørgensen | K. Birkeland | A. Fu | N. Hammar | J. Bodegård | M. Kosiborod | John P H Wilding | R. Holl | P. Fenici | M. Thuresson | M. Cavender | A. Norhammar | Nikita Arya